Literature DB >> 11448292

What is Kearns-Sayre syndrome after all?

T Ashizawa, S H Subramony.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11448292     DOI: 10.1001/archneur.58.7.1053

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  7 in total

Review 1.  Modifier genes for hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

Review 2.  Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.

Authors:  A J Marian; L Salek; S Lutucuta
Journal:  Minerva Med       Date:  2001-12       Impact factor: 4.806

3.  Rapid development of life-threatening complete atrioventricular block in Kearns-Sayre syndrome.

Authors:  L Welzing; J C von Kleist-Retzow; A Kribs; F Eifinger; C Huenseler; N Sreeram
Journal:  Eur J Pediatr       Date:  2008-09-24       Impact factor: 3.183

Review 4.  Genetic determinants of cardiac hypertrophy.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2008-05       Impact factor: 2.161

5.  Causes of Death in Adults with Mitochondrial Disease.

Authors:  Marlieke Barends; Lotte Verschuren; Eva Morava; Victoria Nesbitt; Doug Turnbull; Robert McFarland
Journal:  JIMD Rep       Date:  2015-09-10

6.  Hypoparathyroidism mimicking ankylosing spondylitis and myopathy: a case report.

Authors:  Thayana Ribeiro Kajitani; Renata Viana da Silva; Eloisa Bonfá; Rosa M R Pereira
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  Hypoparathyroidism as the first manifestation of kearns-sayre syndrome: a case report.

Authors:  Farah Ashrafzadeh; Nosrat Ghaemi; Javad Akhondian; Mehran Beiraghi Toosi; Saghi Elmi
Journal:  Iran J Child Neurol       Date:  2013
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.